Published in Lab Business Week, July 17th, 2005
Prior to the completion of the merger and related transactions among Roche Holding Ltd and a Roche affiliate, IGEN International, Inc., (IGEN), and BioVeris on February 13, 2004, the assets and businesses of BioVeris were owned and operated by IGEN and were fully integrated with IGEN.
The financial results have been prepared and are presented as if BioVeris had been operating as a separate entity prior to February 13, 2004, using IGEN's historical cost basis in the assets and liabilities and including the historical operations of the businesses...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.